Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14

• Status: Completed
• Trial end date: 2001-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is the safety and efficacy of Buprenorphine/Naloxone in the treatment of opioid dependence. A compassionate use study.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Institute on Drug Abuse (NIDA)
• Collaborator: New York MDRU
• Treatments: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Heroin; Naloxone

Criteria

Inclusion Criteria:

• Completion of Cooperative Study 1008 A/B

Exclusion Criteria:

• Significant medical or psychiatric illness. Non-compliance with study procedures in the Cooperative Study 1008 A/B